Latest Articles
Antibody therapy points to a new treatment era for primary membranous nephropathy - Drug Discovery News
Antibody therapy points to a new treatment era for primary membranous nephropathy Drug Discovery News
Published: June 16, 2026, 9:19 p.m.
Antibody therapy points to a new treatment era for primary membranous nephropathy - drugdiscoverynews.com
Antibody therapy points to a new treatment era for primary membranous nephropathy drugdiscoverynews.com
Published: June 16, 2026, 9:19 p.m.
'"Please don't take this the wrong way…" I almost didn't reply to this DM about my pregnancy.' - Mamamia
'"Please don't take this the wrong way…" I almost didn't reply to this DM about my pregnancy.' Mamamia
Published: June 16, 2026, 8:48 p.m.
Depo Provera Lawsuit Settlement | June 2026 Litigation Update - Lawsuit Information Center
Depo Provera Lawsuit Settlement | June 2026 Litigation Update Lawsuit Information Center
Published: June 16, 2026, 1:01 p.m.
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case - ThePrint
Bliss IVF Highlights Fertility Success Through Twin Birth in Advanced Endometriosis Case ThePrint
Published: June 16, 2026, 12:31 p.m.
Managing Endometriosis-Associated Pain: A Two-Step Approach - EMJ
Managing Endometriosis-Associated Pain: A Two-Step Approach EMJ
Published: June 16, 2026, 6:33 a.m.
Menstruation: Key to Pregnancy & Reproductive Health - Mirage News
Menstruation: Key to Pregnancy & Reproductive Health Mirage News
Published: June 16, 2026, 4:20 a.m.
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - riauone.com
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 riauone.com
Published: June 15, 2026, 12:29 p.m.
Endometriosis treatments and bone health - Medical Republic
Endometriosis treatments and bone health Medical Republic
Published: June 15, 2026, 3:15 a.m.
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - The Manila Times
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 The Manila Times
Published: June 14, 2026, 10:21 p.m.
Link copied to clipboard!